1-7 of 7
Tania Rodriguez
Close
Sort by
Journal Articles

A Prospective Multicenter Study of Minimal Residual Disease Assessment Using a Next-Generation Immunosequencing Assay and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

Anita Kumar, Jason R. Westin, Stephen J. Schuster, Grzegorz S. Nowakowski, Izidore S. Lossos, Devin Copley, Clare Grieve, Allison P. Jacob, Ashlee Joseph, Leana Laraque, Gita Masand, Chelsea D Mullins, Ellen Napier, Tania Rodriguez, Venkatraman Seshan, Shreya Vemuri, Andrew D. Zelenetz
Journal: Blood
Blood (2021) 138 (Supplement 1): 52.
https://doi.org/10.1182/blood-2021-150572
Published: 2021
Journal Articles

TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1

Lorenz Jahn, Pleun Hombrink, Renate S. Hagedoorn, Michel G. D. Kester, Dirk M. van der Steen, Tania Rodriguez, Tsvetelina Pentcheva-Hoang, Arnoud H. de Ru, Marjolein P. Schoonakker, Miranda H. Meeuwsen, Marieke Griffioen, Peter A. van Veelen, J. H. Frederik Falkenburg, Mirjam H. M. Heemskerk
Journal: Blood
Blood (2017) 129 (10): 1284–1295.
https://doi.org/10.1182/blood-2016-09-737536
Published: 2017
Includes: Supplemental data
Journal Articles

Inducible MyD88/CD40 (iMC) Enhances Proliferation and Survival of Tumor-Specific TCR-Modified T Cells and Improves Anti-Tumor Efficacy in Myeloma

Tsvetelina Pentcheva-Hoang, PhD, David Torres, Tania Rodriguez, PhD, Ana Korngold, PhD, An Lu, Jeannette Crisostomo, Annemarie Moseley, MD PhD, Lorenz Jahn, Mirjam H.M. Heemskerk, PhD, Kevin M Slawin, MD, David M Spencer, PhD, Aaron E Foster, PhD
Journal: Blood
Blood (2016) 128 (22): 4550.
https://doi.org/10.1182/blood.V128.22.4550.4550
Published: 2016
Journal Articles

T Cells Expressing Engager and Costimulatory Molecules for the Immunotherapy of CD19+ Malignancies

Mireya Paulina Velasquez, MD, Kota Iwahori, MD PhD, David L Torres, Sunitha Kakarla, PhD, Caroline Arber, MD, Tania Rodriguez-Cruz, PhD, Claudia Gerken, Xiao-Tong Song, PhD, Stephen Gottschalk, MD
Journal: Blood
Blood (2014) 124 (21): 2433.
https://doi.org/10.1182/blood.V124.21.2433.2433
Published: 2014
Journal Articles

Identification of Leukemia Associated Antigens From ANKRD17 and CDK4 Using Mass Spectrometry Based Screening,

Colleen McGary, BS, Atim A. Enyenihi, PhD, Sally A. Hunsucker, PhD, Patricia A. Ropp, PhD, Tania Rodriguez-Cruz, BS, Gregory Lizee, PhD, Gheath Alatrash, DO, PhD, Gary L. Glish, PhD, Paul M. Armistead, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4020.
https://doi.org/10.1182/blood.V118.21.4020.4020
Published: 2011
Journal Articles

A Novel HLA-A2 Restricted Peptide Derived From Cathepsin G Is An Effective Immunotherapeutic Target for Myeloid Leukemia

Mao Zhang, MPH, Pariya Sukhumalchandra, BS, Atim A. Enyenihi, PhD, Lisa S St. John, PhD, Sally A. Hunsucker, PhD, Kathryn Ruisaard, MS, Zein Al Atrache, Patricia A Ropp, PhD, Tania Rodriguez-Cruz, BS, Elizabeth Mittendorf, MD, Gregory Lizee, PhD, Karen Clise-Dwyer, PhD, Sijie Lu, PhD, Gary L. Glish, PhD, Jeffrey J. Molldrem, MD, Paul M Armistead, MD, PhD, Gheath Alatrash, D.O., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 2986.
https://doi.org/10.1182/blood.V118.21.2986.2986
Published: 2011
Journal Articles

Peripheral Tolerance to PR1 Is Maintained After Uptake of Soluble Proteinas-3 and Neutrophil Elastase

Gheath Alatrash, DO, PhD, Yoko Ono, MD, Anna Sergeeva, PhD, Pariya Sukhumalchandra, BS, Mao Zhang, MPH, Kathryn Quintanilla, MS, Paul Armistead, MD, PhD, Hong He, MD, Tania Rodriguez-Cruz, BS, Karen Clise-Dwyer, PhD, Eric Wieder, PhD, Greg Lizee, PhD, Sijie Lu, PhD, Jeffrey J. Molldrem, MD
Journal: Blood
Blood (2010) 116 (21): 4301.
https://doi.org/10.1182/blood.V116.21.4301.4301
Published: 2010